| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 05/17/2001 | WO2001034637A1 Novel physiologically active peptides and process for producing the same |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034619A1 2-aminopurine derivatives |
| 05/17/2001 | WO2001034617A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
| 05/17/2001 | WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034600A1 Protease inhibitors |
| 05/17/2001 | WO2001034599A1 Protease inhibitors |
| 05/17/2001 | WO2001034597A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
| 05/17/2001 | WO2001034594A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034585A1 Semicarbazone derivatives and their use as thrombopoietin mimetics |
| 05/17/2001 | WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists |
| 05/17/2001 | WO2001034577A1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 05/17/2001 | WO2001034574A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 05/17/2001 | WO2001034572A2 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors |
| 05/17/2001 | WO2001034571A1 β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 05/17/2001 | WO2001034570A1 Nitrogenous heterocycle derivatives |
| 05/17/2001 | WO2001034567A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 05/17/2001 | WO2001034566A2 Protease inhibitors |
| 05/17/2001 | WO2001034565A2 Protease inhibitors |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034203A1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 05/17/2001 | WO2001034202A2 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 05/17/2001 | WO2001034201A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 05/17/2001 | WO2001034174A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | WO2001034167A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | WO2001034162A1 Anti-hiv compositions |
| 05/17/2001 | WO2001034160A1 Protease inhibitors |
| 05/17/2001 | WO2001034159A1 Protease inhibitors |
| 05/17/2001 | WO2001034158A1 Protease inhibitors |
| 05/17/2001 | WO2001034157A1 Protease inhibitors |
| 05/17/2001 | WO2001034156A1 Protease inhibitors |
| 05/17/2001 | WO2001034155A1 Protease inhibitors |
| 05/17/2001 | WO2001034154A1 Protease inhibitors |
| 05/17/2001 | WO2001034153A1 Protease inhibitors |
| 05/17/2001 | WO2001034152A1 Nasal drops containing fused pyridazine derivatives |
| 05/17/2001 | WO2001034145A1 Treating cancer by increasing intracellular malonyl coa levels |
| 05/17/2001 | WO2001034138A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 05/17/2001 | WO2001034137A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | WO2001034127A1 Prevention of plaque rupture by acat inhibitors |
| 05/17/2001 | WO2001034119A2 Inhibitors of crystallization in a solid dispersion |
| 05/17/2001 | WO2001034117A1 A method for chemoprevention of prostate cancer |
| 05/17/2001 | WO2001034099A1 Soy depigmenting and skin care compositions |
| 05/17/2001 | WO2001034093A2 Potentiation of prodrug efficacy |
| 05/17/2001 | WO2001033975A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 05/17/2001 | WO2001033942A1 Method for producing metabolites from plants cultivated in soil-less medium |
| 05/17/2001 | WO2001024796A8 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 05/17/2001 | WO2001019356A3 High lipid diet |
| 05/17/2001 | WO2001014360A3 Benzopyrans and benzothiopyrans as rar selective retinoid agonists |
| 05/17/2001 | WO2001014358A3 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 05/17/2001 | WO2001009116A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 05/17/2001 | WO2001007646A3 Method for quantization of the antiviral effect of antiviral active principles |
| 05/17/2001 | WO2001007602A3 Oligonucleotides for inhibiting the expression of human eg5 |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001005810A3 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 05/17/2001 | WO2001005390A3 Method for treating chronic pain using mek inhibitors |
| 05/17/2001 | WO2001001973A8 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/17/2001 | WO2001001932A3 Oligosaccharide aldonic acids and their topical use |
| 05/17/2001 | WO2000076457A3 Il-8 receptor antagonists |
| 05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/17/2001 | US20010001309 For treating pathologies related to altered alpha v beta 3 integrin-mediated cell attachment, in particular wherein inhibition of angiogenesis is desired, for example in tumors, also associated with metastasis |
| 05/17/2001 | DE19954707A1 Imidazolverbindungen als Phosphodiesterase VII-Hemmer Imidazole compounds as phosphodiesterase VII inhibitor |
| 05/17/2001 | DE19954516A1 Epinastin-haltige Lösungen Epinastine-containing solutions |
| 05/17/2001 | DE19953899A1 Carboxamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | CA2391416A1 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | CA2391299A1 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 05/17/2001 | CA2391277A1 Treating cancer by increasing intracellular malonyl coa levels |
| 05/17/2001 | CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists |
| 05/17/2001 | CA2390975A1 Potentiation of prodrug efficacy |
| 05/17/2001 | CA2390919A1 Nose drop containing condensed pyridazine |
| 05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
| 05/17/2001 | CA2390655A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 05/17/2001 | CA2390530A1 N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
| 05/17/2001 | CA2390501A1 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390376A1 .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis |
| 05/17/2001 | CA2390233A1 2-aminopurine derivatives |
| 05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | CA2390161A1 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389488A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2388918A1 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388729A1 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | CA2388643A1 Use of lytic toxins and toxin conjugates |